The CD13+/CD90−dormant cancer stem cells were further characterized by their association with regulation of the tumor protein p53 (TP53) signaling pathway, which is involved with chemoresistance development upon treatment with genotoxic agents. This evidence concerns the gene ANPEP and cancer.